Autonomous Methadone Delivery System by Nurses
NCT07085377 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 182
Last updated 2025-12-16
Summary
Initiations of methadone treatment for opiode use disorder (OUD) are carried out in France in specialized centers, known as centers for care, support and prevention in addictology (CSAPA) In this way, hospital practitioners initiate the prescription of methadone, which is delivered on the spot by the nursing team. CSAPA nurses, and addictology nurses more generally, have a real range of skills which can include adapting treatment doses according to a protocol pre-established in a team, and medically validated (French law no. 2019-774 of July 24, 2019 relating to the organization and transformation of the healthcare system).
The methadone speciality used for initiation in CSAPAs is almost always the syrup form. The capsule form can only be used after one year's treatment, unless exceptionally authorized by the medical officer of the French National Health Insurance Fund. However, regulations stipulate that the prescription of methadone syrup must be renewed every fourteen days, which in theory means that a CSAPA doctor must see the patient at least twice a month to renew the prescription, throughout the entire course of treatment.
In practice, medical resources are often not sufficient for patients to be seen by a doctor at such a rate. Numerous palliative organizations exist, though they remain poorly described and documented. In some centers, doctors focus primarily on initiations, and prescriptions for patients for whom "stability" has been achieved are sometimes renewed for longer periods than fourteen days, with nurses in charge of assessing whether this organization is suitable for the patient. The notion of stability varies significantly from one center to another, and may mean achieving a constant dose, stopping illicit opioid use, or other criteria more focused on the patient's psychosocial reintegration. By outlining the missions of Addictology nurses, and more specifically of CSAPA nurses, the investigators can define the essential skills required of nurses to carry out these missions.
The main hypothesis of the DIADEME study is that semi-autonomous management of methadone treatment initiation by CSAPA nursing teams helps to reinforce adherence to care and thus improve retention rates in the 3 months following initiation.
Conditions
- Opioid Use Disorder (OUD)
- Addictology
Interventions
- PROCEDURE
-
DIADEME strategy
This strategy consists of implementing the standardized DIADEME protocol. It, in line with best practice recommendations, enables nurses to adjust methadone dosage on the basis of a clinical assessment scheme incorporating opioid withdrawal and overdosing and includes: * initial medical consultation with the hospital practitioner for an addictology and psychiatry assessment, OUD assessment, and initial prescription of methadone for 3 months * ECG prior to any methadone prescription, hepatitis B, C, HIV testing may be offered, and an emergency NALOXONE kit will be given to the patient or prescribed * follow-up consultations with an nurse at least every 7 days, and more frequently if necessary.Dosages can be adjusted by the nurse on the basis of the standardized DIADEME protocol * medical consultation are only in the event of major withdrawal symptoms or overdosing or in the event of any incident not covered by the protocol and warranting rapid medical advice or at the patient's request
- PROCEDURE
-
Controle strategy
The control strategy corresponds to standard practice guidelines for patients suffering from drug addiction, with the care pathway provided by the hospital practitioner, assisted by the nursing team.
- PROCEDURE
-
Individual semi directive interview
Individual semi-directive interviews with a sample of patients from the DIADEME group (2 to 3 volunteer patients per CSAPA for a total of 20 to 30 interviews) will be conducted by a research psychologist and carried out at one month after the end of follow-up (3 months). Themes covered will include: commitment to care, patient/professional relationship, understanding of follow-up and treatment, experience of care and services at the addictology center, satisfaction with services received, level of response to expectations). Individual semi-directive interviews with a sample of healthcare professionals focus group will be also conducted by a research psychologist and carried out after the last patient has been included in the center. The aim will be to understand the effects of the intervention and identify its impact on professionals and the organization of the centers.
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-08
- Primary Completion
- 2028-04-08
- Completion
- 2028-04-08
Countries
- France
Study Locations
More Related Trials
-
Pharmacokinetic Modeling of Methadone
NCT05490732 ·Status: RECRUITING ·Phase: NA
-
Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment
NCT04308694 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.
NCT02062736 ·Status: COMPLETED
-
Prescription Opioid Misuse Assessment
NCT03195374 ·Status: COMPLETED
-
Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers
NCT02926482 ·Status: COMPLETED ·Phase: NA
-
Neonatal and Maternal Effects of Buprenorphine and Methadone
NCT03024736 ·Status: COMPLETED
-
MethaLoad Dose-Finding Study
NCT06877858 ·Status: RECRUITING ·Phase: PHASE1
-
A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment
NCT01416584 ·Status: COMPLETED ·Phase: NA
-
Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their Mothers
NCT01889121 ·Status: COMPLETED
-
Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial
NCT05245513 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution
NCT04059016 ·Status: COMPLETED
-
The German Project of Heroin Assisted Treatment of Opiate Dependent Patients
NCT00268814 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments
NCT02586896 ·Status: COMPLETED ·Phase: NA
-
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
NCT05675735 ·Status: RECRUITING ·Phase: NA
-
Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome
NCT03334981 ·Status: COMPLETED
-
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
NCT00367302 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Entry Into Comprehensive Methadone Treatment Via Interim Maintenance
NCT00712036 ·Status: COMPLETED ·Phase: NA
-
Clinician-patient Interaction During Addiction Consultation
NCT01769651 ·Status: UNKNOWN
-
Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers
NCT02920762 ·Status: UNKNOWN
-
Treatment of Pregnant Women With OUD
NCT04240392 ·Status: COMPLETED ·Phase: NA
-
Pain Self-Management and Treatment Engagement for Patients Taking Opioids
NCT06855732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy
NCT05251376 ·Status: WITHDRAWN ·Phase: PHASE1
-
Content and Expectations of Consultations of Patients With Opioid Substitution Treatment Considered as Stabilized: Cross-Testimonials Doctors - Patients (MSOSuiStab)
NCT03390829 ·Status: UNKNOWN
-
Older Adults, Methadone, and Cognitive Function
NCT07153029 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center
NCT02245685 ·Status: COMPLETED